Novel assessment of epigenetic imprinting biomarkers for the diagnosis of thyroid nodules.
1/5 보강
Caring for individuals with thyroid nodules requires accurate estimation of their risk of thyroid cancer; however, available diagnostic tools offer only imprecise estimates.
APA
Singh Ospina N, Brito JP (2023). Novel assessment of epigenetic imprinting biomarkers for the diagnosis of thyroid nodules.. Nature reviews. Clinical oncology, 20(3), 139-140. https://doi.org/10.1038/s41571-022-00720-3
MLA
Singh Ospina N, et al.. "Novel assessment of epigenetic imprinting biomarkers for the diagnosis of thyroid nodules.." Nature reviews. Clinical oncology, vol. 20, no. 3, 2023, pp. 139-140.
PMID
36646815
Abstract
Caring for individuals with thyroid nodules requires accurate estimation of their risk of thyroid cancer; however, available diagnostic tools offer only imprecise estimates. Novel biomarkers might help to clarify thyroid cancer risk and facilitate more-accurate diagnostic decision-making, although limitations in this area continue to exist.
MeSH Terms
Humans; Thyroid Nodule; Thyroid Neoplasms; Biomarkers; Epigenesis, Genetic; Biomarkers, Tumor